Listed biotechnology company Stirling Products has appointed Gunnar Aberg to its board.
Dr Aberg is one of the inventors and patent holders of Stirling’s animal growth promoter. He is also the chief executive of Florida-based Bridge-Pharma, which is the largest shareholder in Stirling with 11 per cent of the equity.
© Business News 2017. You may share content using the tools provided but do not copy and redistribute.